Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

Share Price is delayed by 15 minutes
Get Live Data
378.60    0.50 (0.13%)
Bid:
376.90
Ask:
377.10
Spread: 0.20 (0.053%)
Market Cap: £7.78b
MKS Live PriceLast checked at - London Stock Exchange

Intraday Marks & Spencer Share Chart

Final Results

20 May 2026 07:00

RNS Number : 9971E
Marks and Spencer Group PLC
20 May 2026
 

MARKS AND SPENCER GROUP PLC

 

PRELIMINARY RESULTS FOR THE 52 WEEKS ENDED 28 MARCH 2026

 

Marks and Spencer Group plc (the "Company") announces its Preliminary Results for the 52 weeks ended 28 March 2026, which are available to view at: http://www.rns-pdf.londonstockexchange.com/rns/9971E_1-2026-5-19.pdf.

 

In compliance with UK Listing Rules 6.4.1(R) and 6.4.3(R), the Preliminary Results in unedited full text have been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism. The Preliminary Results are also available on the Company's corporate website at corporate.marksandspencer.com.

 

Dividend

The Board is proposing a final dividend of 3.0p per share, taking the full-year dividend to 4.2p per share, subject to shareholder approval at the forthcoming Annual General Meeting. If approved, the final dividend will be payable on 10 July 2026 to shareholders on the register of members as at close of business on 5 June 2026. The ordinary shares will be quoted ex dividend on 4 June 2026. For those shareholders electing to participate in the dividend reinvestment plan, the last date for receipt of a new election is 19 June 2026.

 

For further information, please contact:

 

Investor Relations

Fraser Ramzan: +44 (0) 7554 227 758

Helen Lee: +44 (0) 7880 294 990

 

Media Enquiries:

Corporate Press Office: +44 (0) 20 8718 1919

 

Investor & Analyst presentation and Q&A: 

A pre-recorded investor and analyst presentation will be available on the Marks and Spencer Group plc website here from 7:30am on 20 May 2026.

 

Stuart Machin and Alison Dolan will host a Q&A session at 9:30am on 20 May 2026.

 

For the quickest joining experience, please register prior to attending the call here. After registering, you will be given unique dial in details to join the call.

 

Alternatively, you can use the below details to join the call but please join 5-10 minutes before the start time in order to register your details with the operator.

 

Dial in:  +44 (0) 33 0551 0200

Passcode: Quote M&S FY Analyst when prompted by the operator.

Replay: A recording will be available after the call here.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR SFMEEUEMSELI
Date   Source Headline
5th Jun 20201:28 pmRNSHolding(s) in Company
3rd Jun 20209:30 amRNSAnnual Financial Report
2nd Jun 202012:39 pmRNSHolding(s) in Company
1st Jun 20209:00 amRNSTotal Voting Rights
28th May 202010:55 amRNSDirector/PDMR Shareholding
20th May 20207:00 amRNSFinal Results
14th May 202012:45 pmRNSNew Clothing & Home Managing Director - Replace
14th May 202012:13 pmRNSNew Clothing & Home Managing Director
13th May 20204:54 pmRNSHolding(s) in Company
4th May 20206:32 pmRNSHolding(s) in Company
1st May 20209:00 amRNSTotal Voting Rights
30th Apr 20207:00 amRNSDirectorate Change
28th Apr 20203:40 pmRNSDirector/PDMR Shareholding
28th Apr 20207:00 amRNSM&S Strengthened liquidity for Covid crisis
16th Apr 20205:03 pmRNSDirector/PDMR Shareholding
16th Apr 202011:26 amRNSDirector/PDMR Shareholding
6th Apr 20205:51 pmRNSHolding(s) in Company
3rd Apr 20205:22 pmRNSHolding(s) in Company
1st Apr 202012:25 pmRNSTotal Voting Rights
30th Mar 202011:19 amRNSDirector/PDMR Shareholding
25th Mar 202010:28 amRNSHolding(s) in Company
20th Mar 20207:00 amRNSUpdate on trading and impact of COVID-19
11th Mar 20205:53 pmRNSDirector/PDMR Shareholding
10th Mar 20203:40 pmRNSHolding(s) in Company
10th Mar 20207:57 amRNSHolding(s) in Company
5th Mar 20205:57 pmRNSHolding(s) in Company
2nd Mar 20205:47 pmRNSHolding(s) in Company
2nd Mar 20209:00 amRNSTotal Voting Rights
28th Feb 202011:12 amRNSDirector/PDMR Shareholding
27th Feb 20208:59 amRNSHolding(s) in Company
20th Feb 20203:25 pmRNSHolding(s) in Company
11th Feb 20207:00 amRNSDirectorate Change
5th Feb 20201:22 pmRNSDirectorate Change
3rd Feb 20209:00 amRNSTotal Voting Rights
31st Jan 20204:25 pmRNSHolding(s) in Company
28th Jan 202010:31 amRNSDirector/PDMR Shareholding
14th Jan 202010:21 amRNSDirector/PDMR Shareholding
9th Jan 20207:00 amRNS3rd Quarter Trading Statement
3rd Jan 202010:49 amRNSInterim Chief Financial Officer
2nd Jan 20209:00 amRNSBlock listing Interim Review
2nd Jan 20209:00 amRNSTotal Voting Rights
30th Dec 20191:30 pmRNSDirector/PDMR Shareholding
23rd Dec 20194:37 pmRNSHolding(s) in Company
20th Dec 20193:57 pmRNSHolding(s) in Company
11th Dec 20193:45 pmRNSDirector/PDMR Shareholding
6th Dec 20195:02 pmRNSHolding(s) in Company
3rd Dec 201911:21 amRNSHolding(s) in Company
2nd Dec 20199:00 amRNSTotal Voting Rights
29th Nov 20194:58 pmRNSHolding(s) in Company
28th Nov 20194:39 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.